Our purpose in this study was to describe and document perceptions of Kenyan healthcare workers' acceptance and usage of RDTs. The data used in this study were collected at three study sites: Nairobi (urban), Rift Valley (rural), and Central (suburban), comprising both public and private healthcare facilities. These institutions reflect multilayered healthcare services and specializations, offering variability in perceptions and decisions to use RDTs when diagnosing diseases and illnesses. The study mainly targeted medical doctors and clinical officers in a variety of medical specializations and subspecialties from the three study sites. Our study drew a probability sample of 385 healthcare workers using a combination of sampling techniques. We used stratified sampling to draw the health facility-public and private-from a sampling frame of all hospitals in the regions, proportionate sampling was used to obtain samples from each of the three regions, and simple random sampling was used to draw the study participants from a list of all qualified doctors and clinical officers from the selected facilities. Data were collected using a semi-structured interviewer-administered questionnaire for both quantitative (closed-ended) and qualitative (open-ended) inquiries. The validity and reliability of the perceptions scale were established using the Cronbach's alpha (0.81-0.93 for usability and reliability, and 0.23 for adoptability).
Measures
The primary measures used to explore perceptions of Kenyan healthcare workers' acceptance and usage of RDTs were derived from a number of variables organized into three types: 1) knowledge of RDTs, 2) barriers to improving use of RDTs, and 3) the cost associated with RDTs. Knowledge of RDTs was measured in terms of two variables: general knowledge and clinicians' self-reported level of knowledge. General knowledge was gauged through the statement "Rapid diagnostic tests are fundamental in diagnoses in Kenya today." Responses to this question were coded on a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). Self-determined knowledge was gauged by the question "How would you rate your knowledge of rapid diagnostic tests?" Responses to this question were coded on a 5-point scale ranging from 1 (extensive knowledge) to 5 (no knowledge).
We also measured knowledge with two other variables: potential for replacement of microscopy and types of RDTs clinicians were familiar with. Whether clinicians thought RDTs could replace microscopy was gauged through the statement "RDTs can replace laboratory microscopy tests in areas they are unavailable." Reponses to this statement were coded on a 5-point scale ranging from 1 (strongly disagree) to 5 (strongly agree). Types of technologies clinicians were familiar with was gauged by asking participants about a list of potential diagnostic technologies that are commonly used in diagnostic tests. Knowledge of RDTs was also measured in terms of whether clinicians used RDTs for specific diseases, with open-ended responses.
Besides knowledge of RDTs, we also included variables pertaining to barriers to improve the use of RDTs and the cost associated with RDTs. Barriers to improve RDTs were gauged by the question "Have you encountered any barriers in use of RDTs?" with a yes or no option. The cost associated with RDTs was gauged with an open-ended question, "What amount of money would be considered as low-cost RDTs by your patients?"
Development of Survey Instruments
A short 19-question survey with both open-and closed-ended questions was designed to minimize respondents' time commitment (to avoid fatigue) while covering potentially important factors for RDT design. During the pilot testing of the survey, the items' reliability was assessed using the Cronbach's alpha reliability parameter, which assesses the internal consistency or average correlation of items in a survey. Two constructs were assessed: 1) usability (i.e., ease of use) and acceptability (i.e., probability of use) of RDTs in Kenya, and 2) adoptability (i.e., appropriateness of the RDTs to complement symptom-based or other local diagnostic criteria) of RDTs in Kenyan medical settings. Raw scores were used since all the scales used the same points. The usability and acceptability scale had a raw Cronbach's alpha coefficient of 0.81, which is above the 0.7 cutoff value for acceptance [1] . Deleting the item "Disease known" would have improved the coefficient to 0.93, which implies that the item was somehow unrelated to the construct measured or was too general and therefore skewed the construct. We retained the item because of its importance in eventually informing disease priorities in the design of the RDTs, but interpreted the results with this coefficient in mind. The adoptability scale had a lower reliability coefficient of 0.23, with insignificant improvement when deleting any item. Adoptability is a complementary factor and is compounded by questions of technology trust, which were not part of this study. We can use data from the current study to inform data collection in follow-up studies, including technology trust. 
